Intent to Sole Source - Medical/Scientific Instruments for the Department of Transfusion Medicine, NIH Clinical Center
Updated
Special Notice from the National Institutes of Health, for work in Bethesda, Maryland. Due Oct 25, 2026, 12:00 PM (UTC-4), 1 day left.
| Solicitation number | NOI-OLAO-CC-27-000121 |
|---|---|
| Agency | National Institutes of Health |
| Office | National Institutes of Health |
| Notice type | Special Notice |
| Set-aside | None |
| Trade (NAICS) | Analytical Laboratory Instrument Manufacturing (334516) |
| Product or service code | 6640 |
| Place of performance | Bethesda, Maryland |
| Posted | Oct 8, 2026 |
| Response deadline | Oct 25, 2026, 12:00 PM (UTC-4) (1 day left) |
| Add the deadline to | Google Calendar · Apple / Outlook (.ics) |
Official notice and attachments
Description
This is a Notice of Intent, not a request for proposal. The National Institute of Health, Clinical Center (NIH-CC) intends to negotiate on an other than full and open competition basis with the following vendor: Fisher Scientific. Acquisition Description: The NIH Clinical Center, Department of Transfusion Medicine (DTM), Infectious Diseases Section requires acquisition of a
- Real-Time PCR System,
- an Automated Nucleic Acid Extractor and
- a microvolume spectrophotometer to support clinical research and the development, optimization, and validation of diagnostic assays for hepatitis viruses and other transfusion-transmitted pathogens.
The required system must support generation of high-quality quantification data from clinical specimens, including viral RNA/DNA and host-derived nucleic acids. The instrument must enable applications such as targeted genome amplification, work with a wider dynamic detection range, support the library prep for viral genome sequencing, and assay development workflows necessary for evaluating test performance and refining diagnostic methods prior to implementation in a clinical testing environment.
The system must meet the following functional and operational requirements: High data accuracy and reproducibility to ensure reliable detection of viral variants and evaluation of assay performance; Low- to moderate-throughput capability appropriate for assay development, pilot studies, and validation activities involving smaller sample sets; Rapid turnaround times to support iterative testing and optimization of clinical assays; Flexible run configurations that allow efficient processing of varying sample volumes without excess capacity; Cost-efficient operation, including the ability to minimize per-run and per-sample costs for pathogen detection; Integrated and streamlined workflows, including nucleic acid extraction, amplification, quantification and data analysis within a platform from the same vendor to reduce complexity and variability; Ease of use and standardized operation, supporting reproducibility and implementation in a clinical laboratory environment; Compatibility with established nucleic acid preparation and amplification methods and existing laboratory workflows.
The flexibility to be using the systems in a CLIA certified environment. The statutory authority for this sole source requirement is 41 U.S.C. 253(c) (1) as implemented by FAR 6.302-1 only one responsible source and no other supply of service will satisfy agency requirements. This is not a request for proposal.
All responsible sources that could provide the required may submit a capability statement that will be considered by email (subject line to reference NOI-OLAO-CC-27-000121) by 12:00 PM eastern standard time on 10/23/2026 to: [email protected]. All responses received by the closing date of this synopsis will be considered by the Government. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government.
Is your business small enough?
For NAICS 334516, a business counts as small if it has no more than 1,000 employees (SBA size standard). This notice is set aside, so only businesses under that size, or in the named program, can bid. SBA table, current as of Oct 15, 2026.
Notice history
- Oct 8, 2026: Special Notice Due Oct 23, 2026, 12:00 PM (UTC-4)
Companies that win this kind of work
Federal contractors paid for analytical laboratory instrument manufacturing work, who also hold NIH contracts (last 12 months): possible competitors, or partners to team with.
- Abbott Laboratories Inc. $92.0 million in this trade
- Roche Diagnostics Corporation $66.7 million in this trade
- Beckman Coulter, Inc $63.1 million in this trade
- Government Scientific Source Inc $41.1 million in this trade
- Agilent Technologies Inc $31.0 million in this trade
About the buyer
The National Institutes of Health awarded $5.8 billion in contracts in the last 12 months; its biggest suppliers were Leidos Biomedical Research Inc, M. A. Mortenson Company and Deloitte Consulting LLP. See what NIH is buying now.
Analytical Laboratory Instrument Manufacturing contracts right now
There are 63 open government contract opportunities in this trade (NAICS 334516), 24 posted in the last 7 days; 37% are set aside for small businesses. The agencies buying the most are Department of Veterans Affairs, Department of the Navy and Department of Energy. Most of the work with a stated place is in Maryland, District of Columbia and New Mexico. A notice in this trade gives a median of 14 days from posting to deadline; this one gives 17 days.
All open analytical laboratory instrument manufacturing contracts
Coming up in this trade
Planned contracts from the agencies' procurement forecasts, often months before a solicitation. Plans can change.
Recent awards in this trade
- DLA Aerospace LLC $111,336 · Defense Logistics Agency · Oct 23, 2026
- VWR International LLC $49.5 million · Defense Logistics Agency · Oct 21, 2026
- Werfen USA LLC $1.6 million · Department of Veterans Affairs · Oct 13, 2026
- Seahorse Defense Supply, LLC $342,437 · Defense Logistics Agency · Oct 13, 2026
- Hologic Sales And Service, LLC $58,190 · Department of Veterans Affairs · Oct 8, 2026
From the award notices agencies publish.